BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Factor Viia

Below is an extended Factor Viia research listing. Click here to return to the Factor Viia main in depth entry.

Recent Publications on Factor Viia:

"Primary prophylaxis" with rFVIIa in a patient with severe haemophilia a and inhibitor.
The development of antibodies that inhibit or neutralize replacement...
Direct Link
4th October, 2008
Haematology Department, Hospital Universitario La Paz, Paseo de la
Hematologic effects of recombinant factor VIIa combined with hemoglobin-based oxygen carrier-201 for prehospital resuscitation of swine with severe uncontrolled hemorrhage due to liver injury.
The combination of traumatic injury, hemorrhage, and fluid resuscitation...
Direct Link
4th October, 2008
aNaval Medical Research Center, Silver Spring, USA bUniformed Services
Surgery of cerebral trauma and associated critical care.
The last 30 years have been both exciting and frustrating for those in the...
Direct Link
1st October, 2008
Department of Neurosurgery, University of Texas Medical School at Houston,
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Women with antiphospholipid syndrome (APS), a condition characterized by...
Direct Link
20th September, 2008
Hospital for Special Surgery, Weill Medical College of Cornell University,
Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials.
We reassess all published randomized controlled trials that have evaluated...
Direct Link
20th September, 2008
Department of Anesthesiology, University of Montreal, Quebec, Canada.
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism.
Amniotic fluid embolism is a rare and often fatal complication of...
Direct Link
13th September, 2008
Department of Obstetrics Gynecology and Reproductive Sciences, Mount Sinai
[The use of recombinant activated factor VIIa for major bleedings in open heart surgery] 12th September, 2008
Diagnosis and treatment of peripartum bleeding.
Abstract Severe peripartum hemorrhage (PPH) contributes to maternal...
Direct Link
12th September, 2008
1Department of Obstetrics, Charite - University Medicine Berlin, 13353
Local and systemic hemostatics in trauma: a review. 11th September, 2008
Department of Surgery, Division of Trauma and Critical Care, University of
Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity.
INTRODUCTION: Incidence of thromboembolic (TE) disease varies with race...
Direct Link
9th September, 2008
Global Development, Novo Nordisk A/S, Bagsvaerd, Denmark,
Recently published papers: Renal replacement therapy: which route and how much? Intracerebral haematomas: does the size matter? beta blockers and steroids: will we ever know?
ABSTRACT: Femoral access for renal replacement therapy appears to have a...
Direct Link
6th September, 2008
Department of Critical Care, Worthing Hospital, Lyndhurst Road, Worthing
Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA.
ABSTRACT: Femoral access for renal replacement therapy appears to have a...
Direct Link
2nd September, 2008
Divisions of Hematology and Oncology, Huntsman Cancer Institute, Salt Lake
A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage.
BACKGROUND: Internationally, Factor IX complex (FIX complex) has been used...
Direct Link
30th August, 2008
Department of Surgery, Cedars-Sinai Medical Center, 8700 Beverly Blvd.,
Factor VIIa (recombinant) for acute traumatic hemorrhage.
PURPOSE: The use of factor VIIa (recombinant) for the treatment of acute...
Direct Link
21st August, 2008
Department of Pharmacy Practice and Science, College of Pharmacy,
Factor VIIa for ICH: behind the scenes of an academic-industry collaborative trial.
Amniotic fluid embolism is a rare and often fatal complication of...
Direct Link
19th August, 2008
Columbia University College of Physicians & Surgeons, New York, NY 10032,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional